BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35383393)

  • 1. What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology group (DAG).
    Amsler E; Assier H; Soria A; Bara C; Ferrier le Bouëdec MC; Barbaud A; Milpied B; Giordano-Labadie F; Pasteur J; Badaoui A; Valois A; Castelain F; Kurihara F; Castagna J; Boulard C; Bernier C; Leleu C; Marcant P; Crépy MN; Tetart F; Raison-Peyron N;
    Contact Dermatitis; 2022 Aug; 87(2):170-175. PubMed ID: 35383393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix I.
    Bruze M; Engfeldt M; Ofenloch R; Elsner P; Goncalo M; Isaksson M; Naldi L; Schuttelaar ML; Svensson Å; Diepgen T
    Br J Dermatol; 2020 Apr; 182(4):955-964. PubMed ID: 31206595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic reactivity for different dilutions of eugenol in repeated open application test and patch testing.
    Ofenloch RF; Andersen KE; Foti C; Giménez-Arnau AM; Mowitz M; Salvador JFS; Svedman C; Bruze M
    Contact Dermatitis; 2023 Aug; 89(2):95-102. PubMed ID: 37218587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nickel allergy: relationship between patch test and repeated open application test thresholds.
    Fischer LA; Johansen JD; Menné T
    Br J Dermatol; 2007 Oct; 157(4):723-9. PubMed ID: 17634081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix II: the EDEN Fragrance Study.
    Bruze M; Engfeldt M; Elsner P; Gonçalo M; Naldi L; Schuttelaar MLA; Svedman C; Svensson Å; Ofenloch R
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1692-1701. PubMed ID: 33914959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyisohexyl 3-cyclohexene carboxaldehyde allergy: relationship between patch test and repeated open application test thresholds.
    Fischer LA; Menné T; Avnstorp C; Kasting GB; Johansen JD
    Br J Dermatol; 2009 Sep; 161(3):560-7. PubMed ID: 19486000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyldibromoglutaronitrile allergy: relationship between patch test and repeated open application test thresholds.
    Fischer LA; Johansen JD; Menné T
    Br J Dermatol; 2008 Nov; 159(5):1138-43. PubMed ID: 18795931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative patch and repeated open application testing in methyldibromo glutaronitrile-sensitive patients.
    Schnuch A; Kelterer D; Bauer A; Schuster Ch; Aberer W; Mahler V; Katzer K; Rakoski J; Jappe U; Krautheim A; Bircher A; Koch P; Worm M; Löffler H; Hillen U; Frosch PJ; Uter W
    Contact Dermatitis; 2005 Apr; 52(4):197-206. PubMed ID: 15859992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated open application test with methyldibromo glutaronitrile, a multicentre study within the EECDRG.
    Gruvberger B; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Frosch PJ; Goossens A; Lahti A; Maibach HI; Menné T; Orton D; Seidenari S
    Contact Dermatitis; 2005 Jan; 52(1):19-23. PubMed ID: 15701125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic contact dermatitis caused by hydroperoxides of limonene and dose-response relationship-A repeated open application test (ROAT) study.
    Bennike NH; Palangi L; Christensson JB; Nilsson U; Zachariae C; Johansen JD; Hagvall L
    Contact Dermatitis; 2019 Apr; 80(4):208-216. PubMed ID: 30378136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of positive patch test reactions to lanolin: A ROAT study.
    Uldahl A; Engfeldt M; Svedman C
    Contact Dermatitis; 2021 Jan; 84(1):41-49. PubMed ID: 32844454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated open application tests with methyldibromoglutaronitrile in dermatitis patients with and without hypersensitivity to methyldibromoglutaronitrile.
    Isaksson M; Gruvberger B; Bruze M
    Dermatitis; 2007 Dec; 18(4):203-7. PubMed ID: 18021599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utilization of Repeated Open Application Test Among American Contact Dermatitis Society Members.
    Brown GE; Botto N; Butler DC; Murase JE
    Dermatitis; 2015; 26(5):224-9. PubMed ID: 26367205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study aimed at finding a suitable eugenol concentration for a leave-on product for use in a repeated open application test.
    Svedman C; Engfeldt M; Api AM; Politano VT; Belsito DV; Isaksson M; Bruze M
    Contact Dermatitis; 2012 Mar; 66(3):137-9. PubMed ID: 22320668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The repeated open application test (ROAT).
    Hannuksela M; Salo H
    Contact Dermatitis; 1986 Apr; 14(4):221-7. PubMed ID: 2941220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a specific eyelid patch test series useful? Results of a French prospective study.
    Assier H; Tetart F; Avenel-Audran M; Barbaud A; Ferrier-le Bouëdec MC; Giordano-Labadie F; Milpied B; Amsler E; Collet E; Girardin P; Soria A; Waton J; Truchetet F; Bourrain JL; Gener G; Bernier C; Raison-Peyron N;
    Contact Dermatitis; 2018 Sep; 79(3):157-161. PubMed ID: 29882592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes.
    Fischer LA; Voelund A; Andersen KE; Menné T; Johansen JD
    Contact Dermatitis; 2009 Oct; 61(4):201-8. PubMed ID: 19825091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch testing with a new fragrance mix - reactivity to the individual constituents and chemical detection in relevant cosmetic products.
    Frosch PJ; Rastogi SC; Pirker C; Brinkmeier T; Andersen KE; Bruze M; Svedman C; Goossens A; White IR; Uter W; Arnau EG; Lepoittevin JP; Johansen JD; Menne T
    Contact Dermatitis; 2005 Apr; 52(4):216-25. PubMed ID: 15859994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated open application tests (ROAT) in patients allergic to colophony--evaluated visually and with bioengineering techniques.
    Färm G
    Acta Derm Venereol; 1998 Mar; 78(2):130-5. PubMed ID: 9534892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving povidone-iodine and iodine preparations for patch testing.
    Forkel S; Beutner C; Amschler K; Schröder SS; Schön MP; Geier J; Buhl T
    Contact Dermatitis; 2021 May; 84(5):332-337. PubMed ID: 33306197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.